Medication-induced postural tremor
Fine tremor occurring during attempts to maintain a posture that has developed in association with use of a medication
Medication-Induced MovementG25.1
Loading…
Fine tremor occurring during attempts to maintain a posture that has developed in association with use of a medication
Involuntary movements (tardive dystonia: sustained/repetitive muscle contractions; tardive akathisia: subjective restlessness + repetitive movements) developing in association with neuroleptic use, persisting ≥4 weeks
Dopamine antagonist exposure (antipsychotic or antiemetic) and development of severe muscle rigidity and elevated temperature
Cessation or reduction of heavy/prolonged alcohol use
Parkinsonian tremor, muscular rigidity, or akinesia developing in association with medication use (most commonly neuroleptic/antipsychotic or dopamine-depleting agent)
Medication-induced movement symptoms causing clinically significant distress or impairment
Intoxication: recent sedative/hypnotic/anxiolytic use; Withdrawal: cessation/reduction after prolonged heavy use
≥3 of 12 catatonia symptoms: stupor; catalepsy; waxy flexibility; mutism; negativism; posturing; mannerism; stereotypy; agitation; grimacing; echolalia; echopraxia
Disturbance of attention (reduced ability to direct, focus, sustain, shift attention) and awareness (reduced orientation to environment)
≥1 symptom of altered voluntary motor or sensory function
Persistent difficulties in acquisition and use of language across modalities (spoken, written, sign, or other) due to deficits in comprehension or production, including reduced vocabulary, limited sentence structure, and impairments in discourse
Persistent difficulty with speech sound production that interferes with speech intelligibility or prevents verbal communication of messages